Pharmacokinetics and Efficacy of Generic Melphalan Is Comparable to Innovator Formulation in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Pharmacokinetics and therapeutic efficacy were investigated in patients with multiple myeloma receiving both generic and innovator melphalan (MEL) formulation for conditioning pre autologous stem cell transplantation. Both the MEL formulations were comparable in terms of pharmacokinetics and efficac...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Lymphoma Myeloma Leuk
Autores principales: Pai, Aswin Anand, Devasia, Anup J., Panetta, John Carl, Mani, Sathya, Illangeswaran, Raveen Stephen Stallon, Mohanan, Ezhilpavai, Balakrishnan, Balaji, Lakshmi, Kavitha M., Kulkarni, Uday, Aboobacker, Fouzia N., Korula, Anu, Abraham, Aby, Srivastava, Alok, Mathews, Vikram, George, Biju, Balasubramanian, Poonkuzhali
Formato: Artigo
Lenguaje:Inglês
Publicado: 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7115908/
https://ncbi.nlm.nih.gov/pubmed/31791694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2019.08.013
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares